MDxHealth to Participate in Piper Sandler Healthcare Conference
MDxHealth (NASDAQ: MDXH) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York City, scheduled for December 3-5, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MDxHealth (NASDAQ: MDXH) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York City, scheduled for December 3-5, 2024. CEO Michael K. McGarrity will engage in a fireside discussion on Wednesday, December 4, from 3:00-3:25 pm ET. The discussion will be available via live webcast, accessible through the company's investor page, with replays available for 60 days following the event.
Details
News Market Reaction – MDXH
The recorded move for MDXH in the trading session of this news was -0.53%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MDxHealth to Participate in Piper Sandler Healthcare Conference
IRVINE, CA – November 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, will participate in the Piper Sandler 36th Annual Healthcare Conference, which will take place between Dec 3-5, 2024, in New York City.
Piper Sandler 36th Annual Healthcare Conference
Fireside discussion: Wednesday, December 4, 3:00-3:25 pm ET
Webcast: https://event.webcasts.com/starthere.jsp?ei=1699716&tp_key=9f5393d579
A live webcast of the fireside chat will be accessible on the Investor page of mdxhealth’s website at https://mdxhealth.com/presentations-events/. Replays will be available for up to 60 days following each event.
About mdxhealth®
Mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
For more information:
LifeSci Advisors (IR & PR)
US: +1 949 271 9223
NOTE: The mdxhealth logo, mdxhealth, Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate Score, GPS and Monitor mdx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.